Orange Book product · Brand (NDA)
PHOSLYRA
CALCIUM ACETATE
At a glance
Apr 18, 2011
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 18, 2011
15 yr 5 mo ago
Today
Patent 8592480 expires
Listed method-of-use patent (U-1469) expiration.
Jul 20, 2027
in 1 yr 1 mo
Patent 9089528 expires
Listed method-of-use patent (U-1469) expiration.
Jul 20, 2027
in 1 yr 1 mo
Patent 8591938 expires
Listed drug product patent expiration.
Feb 23, 2030
in 3 yr 9 mo
Pharmaceutical detail
Active ingredient
CALCIUM ACETATE
Strength
667MG/5ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 022581
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2001PHOSLOBrand (NDA)
NDA 021160 · FRESENIUS MEDCL CARE
- 1990PHOSLOBrand (NDA)
NDA 019976 · FRESENIUS MEDCL CARE
- 2023CALCIUM ACETATEGeneric (ANDA)
ANDA 217205 · SQUARE PHARMS
- 2020CALCIUM ACETATEGeneric (ANDA)
ANDA 211038 · SUVEN PHARMS
- 2016CALCIUM ACETATEGeneric (ANDA)
ANDA 203298 · LOTUS PHARM CO LTD
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 203179 · MPP PHARMA
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 202127 · LUPIN
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 202315 · HERITAGE PHARMS INC
- 2015CALCIUM ACETATEGeneric (ANDA)
ANDA 202885 · HERITAGE PHARMS INC
- 2014CALCIUM ACETATEGeneric (ANDA)
ANDA 201658 · AMNEAL PHARMS
- 2013CALCIUM ACETATEGeneric (ANDA)
ANDA 203135 · INVAGEN PHARMS
- 2013CALCIUM ACETATEGeneric (ANDA)
ANDA 202420 · CHARTWELL MOLECULAR
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8592480 | Jul 20, 2027 | in 1 yr 1 mo | U-1469 |
| 9089528 | Jul 20, 2027 | in 1 yr 1 mo | U-1469 |
| 8591938 | Feb 23, 2030 | in 3 yr 9 mo | ProductU-1469 |

